missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Epratuzumab Chimeric Recombinant Rabbit Monoclonal Antibody (hL22 (Epratuzumab))
Rabbit Recombinant Monoclonal Antibody
Marque: Invitrogen™ MA548052
Les retours ne sont pas autorisés pour ce produit.
Afficher la politique du retour.
Description
Specificity: This antibody is specific for the 3rd Ig-like domain of human CD22 (epitope B), a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells.
Epratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.
Spécification
| Epratuzumab Chimeric | |
| Recombinant Monoclonal | |
| 1 mg/mL | |
| PBS with 0.02% ProClin 300 | |
| Rabbit | |
| Protein A | |
| RUO | |
| Human, Rhesus Macaque, Cynomolgus Monkey | |
| Antibody | |
| IgG κ |
| Flow Cytometry, Inhibition Assays, Immunoprecipitation | |
| hL22 (Epratuzumab) | |
| Unconjugated | |
| 90Y-DOTA-hLL2; 90Y-epratuzumab tetraxetan; 90Y-hLL2; AMG-412; hLL2 | |
| This antibody was prepared by the humanization of LL2 (EPB-2), a murine anti-CD22 IgG2a raised against Raji Burkitt lymphoma cells. | |
| 200 μg | |
| Primary | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Correction du contenu d'un produit
Veuillez fournir vos retours sur le contenu du produit en remplissant le formulaire ci-dessous.
Nom du produit
Vous avez repéré une opportunité d'amélioration ?Partager une correction de contenu